Document is current
Any future updates will be listed below
-
Authors
Hsieh, Po-Hung http://orcid.org/0000-0003-1744-4815
Kacew, Alec J.
Dreyer, Marie
Serritella, Anthony V.
Knoebel, Randall W.
Strohbehn, Garth W. http://orcid.org/0000-0003-2973-3040
Ratain, Mark J.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (T32GM007019)
- License Information
-
More Information
Article History
Received: 30 March 2021
Accepted: 2 February 2022
First Online: 14 March 2022
Competing interests
: This work was funded by Clinical Therapeutics Training Grant (T32GM007019) (P.H.) and Richard and Debra Gonzalez Fellowship (G.W.S.). G.W.S. is an employee of the United States Federal Government; the views expressed in this article are those of the authors alone and do not necessarily represent those of the United States Federal Government. G.W.S. and M.J.R. serve in uncompensated Director roles for the Optimal Cancer Care Alliance.
: The University of Chicago Biological Sciences Division Institutional Review Board approved the study with waiver of informed consent by criteria set forth in the 2018 Update to the Common Rule, owing to the no greater than minimal risk nature of the study, the impracticability, and potential introduction of bias of conducting research into home location if written authorization were required, the study’s requirement for identifiable information, and the absence of impact on subjects’ rights and welfare (IRB protocol 20-0065).
